Hae Young Ko

Dr. Hae Young Ko

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
HKHyukjun Kwon
Hyukjun Kwon
MYMinji Yun
Minji Yun
TKTaek-Hyun Kwon
Taek-Hyun Kwon
MBMinji Bang
Minji Bang
JLJungsul Lee
Jungsul Lee
KCKyuha Chong
Kyuha Chong
Glioblastoma (GBM) is a representative malignant brain tumor characterized by a dismal prognosis, with survival rates of less than 2 years and high recurrence rates. Despite surgical resection and several alternative treatments, GBM remains a refractory disease due to its aggressive invasiveness and resistance to anticancer therapy. In this report, we explore the role of fibronectin type III domain containing 3B (FNDC3B) and its potential as a prognostic and therapeutic biomarker in GBM. GBM exhibited a significantly higher cancer-to-normal ratio compared to other organs, and patients with high FNDC3B expression had a poor prognosis (p < 0.01). In vitro studies revealed that silencing FNDC3B significantly reduced the expression of Survivin, an apoptosis inhibitor, and also reduced cell migration, invasion, extracellular matrix adhesion ability, and stem cell properties in GBM cells. Furthermore, we identified that FNDC3B regulates PTEN/PI3K/Akt signaling in GBM cells using MetaCore integrated pathway bioinformatics analysis and a proteome profiler phospho-kinase array with sequential western blot analysis. Collectively, our findings suggest FNDC3B as a potential biomarker for predicting GBM patient survival and for the development of treatment strategies for GBM.

19 October 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
HKHyukjun Kwon
Hyukjun Kwon
MYMinji Yun
Minji Yun
MBMinji Bang
Minji Bang
JLJungsul Lee
Jungsul Lee
YLYeo Song Lee
Yeo Song Lee
KCKyuha Chong
Kyuha Chong
Glioblastoma (GBM) is a representative malignant brain tumor characterized by a dismal prognosis, with survival rates of less than 2 years and high recurrence rates. Despite surgical resection and several alternative treatments, GBM remains a refractory disease due to its aggressive invasiveness and resistance to anticancer therapy. In this report, we explore the role of fibronectin type III domain containing 3B (FNDC3B) and its potential as a prognostic and therapeutic biomarker in GBM. GBM exhibited a significantly higher cancer-to-normal ratio compared to other organs, and patients with high FNDC3B expression had a poor prognosis (p < 0.01). In vitro studies revealed that silencing FNDC3B significantly reduced the expression of Survivin, an apoptosis inhibitor, and also reduced cell migration, invasion, extracellular matrix adhesion ability, and stem cell properties in GBM cells. Furthermore, we identified that FNDC3B regulates PTEN/PI3K/Akt signaling in GBM cells using MetaCore integrated pathway bioinformatics analysis and a proteome profiler phospho-kinase array with sequential western blot analysis. Collectively, our findings suggest FNDC3B as a potential biomarker for predicting GBM patient survival and for the development of treatment strategies for GBM.

14 April 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
HKHae Young Ko
Hae Young Ko
JCJee-In Chung
Jee-In Chung
DKDongwoo Kim
Dongwoo Kim
YPYongmin Mason Park
Yongmin Mason Park
HJHan Hee Jo
Han Hee Jo
MYMijin Yun
Mijin Yun
Summary: Glioblastoma multiforme (GBM) is a devastating brain tumor with dismal prognosis of only 15-month survival regardless of surgical resection. Here, we report an advanced neuroimaging technique combining 11 C-acetate PET and MRI (AcePET), visualizing the boundary beyond the MRI-defined tumor. Targeted biopsy of the regions with increased 11 C-acetate uptake revealed the presence of reactive astrocytes with enhanced acetate-transporter MCT1, along with cancer stem cells. Reactive astrogliosis and MCT1-dependent 11 C-acetate-uptake were recapitulated in U87MG-orthotopic models. Mechanistically, glycolytic tumor cells release excessive acetate causing reactive astrogliosis, leading to the release of aberrant astrocytic GABA and H 2 O 2 , which further down-regulate the neuronal glucose uptake through GLUT3. Clincally, AcePET-guided surgery allows complete tumor resection of infiltrating cancer stem cells and extends the overall survival of patients by 5.25 months compared to conventional MRI-guided surgery. We established a new concept of the metabolic interactions between GBM cells and neighboring neurons through reactive astrocytes and developed AcePET-guided surgery to fight against GBM.

2 June 2025 in International Journal of Radiation Biology
Verified
Journal Article
Closed access
HYHyo Jin Yoon
Hyo Jin Yoon
HKHae Young Ko
Hae Young Ko
SYSu San Yang
Su San Yang
SKSoon Woo Kwon
Soon Woo Kwon
MCMinsu Cho
Minsu Cho
YLYang Hee Lee
Yang Hee Lee
Cytogenetic biodosimetry is used for radiation dose assessment by evaluating chromosomal aberrations in peripheral blood lymphocytes. However, high-dose radiation may cause low absolute lymphocyte counts (ALCs), making it difficult to obtain sufficient metaphase spreads for analysis. This study aimed to optimize centrifugation settings to enrich metaphase spreads, particularly for lymphocytopenic patients. Peripheral blood samples from four healthy donors and one lymphocytopenic patient were collected. Lymphocytes were harvested using one of four centrifugation settings. After an additional low-speed centrifugation step (200 × g for 1 minute) in each experiment, we evaluated slide quality using mitotic index (MI) and metaphase frequency (MF), which were calculated by the number of metaphases and blasts using Metafer 4 software. We established an automatic measurement method for metaphases and blasts, adjusting the settings of Metafer 4. In four healthy donors, the strongest centrifugation (Exp. 4, 879 × g for 5 minutes) yielded the highest number of 'all cells' after harvest. Incorporating an additional low-speed centrifugation step significantly increased MF by 1.5- to 2-fold across all settings, with the greatest improvement observed in Exp. 4. This approach was applied to a lymphocytopenic patient, resulting in a 3.5-fold improvement of MF and the production of high-quality slides. MI was not significantly affected by centrifugation. The combined high-speed and additional low-speed centrifugation method increased MF, improved slide quality by eliminating lower-density cells, and made it easier to analyze metaphase spreads. This method could be used for obtaining sufficient metaphase spreads in lymphocytopenic patients.